- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 263/48 - Nitrogen atoms not forming part of a nitro radical
Patent holdings for IPC class C07D 263/48
Total number of patents in this class: 200
10-year publication summary
|
13
|
15
|
14
|
21
|
11
|
12
|
9
|
8
|
6
|
7
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Sareum Limited | 20 |
11 |
| Cytokinetics, Inc. | 279 |
7 |
| Epigen Biosciences, Inc. | 13 |
7 |
| Oryzon Genomics S.A. | 106 |
5 |
| Bayer Cropscience AG | 2040 |
4 |
| The General Hospital Corporation | 4740 |
4 |
| Romark Laboratories L.C. | 52 |
4 |
| Shionogi & Co., Ltd. | 852 |
4 |
| Lifearc | 43 |
4 |
| The Regents of the University of California | 19961 |
3 |
| DSM IP Assets B.V. | 5585 |
3 |
| Dompé Farmaceutici S.p.A. | 266 |
3 |
| Japan Tobacco Inc. | 3596 |
3 |
| Max-delbruck-centrum fur Molekulare Medizin | 50 |
3 |
| Plexxikon Inc. | 151 |
3 |
| Omeicos Therapeutics GmbH | 7 |
3 |
| Exonate Limited | 15 |
3 |
| Desai, Laxman S. | 3 |
3 |
| Libra Therapeutics, Inc. | 10 |
3 |
| Glaxo Group Limited | 4063 |
2 |
| Other owners | 118 |